Muneshige, K.; Inahashi, Y.; Itakura, M.; Iwatsuki, M.; Hirose, T.; Inoue, G.; Takaso, M.; Sunazuka, T.; Ohashi, Y.; Ohta, E.;
et al. Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells. Pharmaceuticals 2023, 16, 5.
https://doi.org/10.3390/ph16010005
AMA Style
Muneshige K, Inahashi Y, Itakura M, Iwatsuki M, Hirose T, Inoue G, Takaso M, Sunazuka T, Ohashi Y, Ohta E,
et al. Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells. Pharmaceuticals. 2023; 16(1):5.
https://doi.org/10.3390/ph16010005
Chicago/Turabian Style
Muneshige, Kyoko, Yuki Inahashi, Makoto Itakura, Masato Iwatsuki, Tomoyasu Hirose, Gen Inoue, Masashi Takaso, Toshiaki Sunazuka, Yoshihisa Ohashi, Etsuro Ohta,
and et al. 2023. "Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells" Pharmaceuticals 16, no. 1: 5.
https://doi.org/10.3390/ph16010005
APA Style
Muneshige, K., Inahashi, Y., Itakura, M., Iwatsuki, M., Hirose, T., Inoue, G., Takaso, M., Sunazuka, T., Ohashi, Y., Ohta, E., & Uchida, K.
(2023). Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells. Pharmaceuticals, 16(1), 5.
https://doi.org/10.3390/ph16010005